Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Www.arcutis.com save search
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-14 (Crawled : 21:00) - arcutis.com
ARQT | $8.965 0.28% 680K
|
Health Technology
|
| O: 1.08%
H: 0.88%
C: 0.44%
therapeutics nasdaq report iot grant granted
Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners
Published: 2021-12-23 (Crawled : 13:30) - arcutis.com
ARQT | $8.965 0.28% 680K
|
Health Technology
|
| O: 1.67%
H: 8.12%
C: 6.63%
therapeutics iot
FDA Accepts Arcutis Biotherapeutics’ New Drug Application for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
Published: 2021-12-22 (Crawled : 22:00) - arcutis.com
ARQT | $8.965 0.28% 680K
|
Health Technology
|
| O: 1.67%
H: 8.12%
C: 6.63%
new drug fda application drug therapeutics psoriasis iot fda acceptance plague
Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary
Published: 2021-12-16 (Crawled : 13:30) - arcutis.com
HALO M | $39.31 1.55% 170K
|
Health Technology
|
| O: 7.25%
H: 1.86%
C: -3.68%
ARQT | $8.965 0.28% 680K
|
Health Technology
|
| O: 8.01%
H: 3.29%
C: 2.42%
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.